Deepak Agarwal*, Praveen Chahar, Mark Chmiela, Afrin Sagir, Arnold Kim, Faysal Malik and Ehab Farag Pages 2123 - 2132 ( 10 )
Multimodal, non-opioid based analgesia has become the cornerstone of ERAS protocols for effective analgesia after spinal surgery. Opioid side effects, dependence and legislation restricting long term opioid use has led to a resurgence in interest in opioid sparing techniques. The increasing array of multimodal opioid sparing analgesics available for spinal surgery targeting novel receptors, transmitters, and altering epigenetics can help provide an optimal perioperative experience with less opioid side effects and long-term dependence. Epigenetic mechanisms of pain may enhance or suppress gene expression, without altering the genome itself. Such mechanisms are complex, dynamic and responsive to environment. Alterations that occur can affect the pathophysiology of pain management at a DNA level, modifying perceived pain relief. In this review, we provide a brief overview of epigenetics of pain, systemic local anesthetics and neuraxial techniques that continue to remain useful for spinal surgery, neuropathic agents, as well as other common and less common target receptors for a truly multimodal approach to perioperative pain management.
Epigenetics of pain, liposomal bupivacaine, ketamine, spinal surgery, multimodal opioid, pathophysiology.
Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio